
    
      Mono-center, double-blind, 1:1 randomized, placebo-controlled trial 18 treated patients, 9
      patients per group.

      Patients will be randomly assigned to treatment with NT 201 or placebo in a ratio of 1:1. In
      addition, within each treatment group patients will be randomly assigned to injection into
      the left or right soft palate.

      Primary variable:

      Comparison of the ratio of snoring time over sleeping time (Snoring Index). Other secondary
      variables will be analysed.
    
  